A Trial of SHR0302Base in Patients With Vitiligo

PHASE2RecruitingINTERVENTIONAL

Enrollment

152

Participants

Timeline

Start Date

February 11, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2026

Conditions

Vitiligo

Interventions

DRUG

SHR0302Base gel

SHR0302Base gel.

DRUG

SHR0302Base gel placebo

SHR0302Base gel placebo.

Trial Locations (1)

RECRUITING

Dermatology Hospital affiliated to Shandong First Medical University, Jinan

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY